Search





Search





Markets
/
Stocks
/
nasdaq-odtx
/

Odyssey Therapeutics Ord Shs (Proposed)

ODTX

Add to Watchlist

18.060USD

0.0000.00%

Close 06/26, 16:00（ET）Quotes delayed by 15 min

128.67MMarket Cap

LossP/E TTM

Odyssey Therapeutics Ord Shs (Proposed)

18.060

0.0000.00%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can find the annual or quarterly income statement of Odyssey Therapeutics Ord Shs (Proposed) here for insights into the performance and operational efficiency of Odyssey Therapeutics Ord Shs (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2024Q4

Total revenue

--0.00

--1.75M

Revenue

--0.00

--1.75M

Operating expenses

--39.67M

--38.88M

R&D expenses

--32.91M

--31.48M

Depreciation, depletion, and amortization

--1.17M

--1.29M

Operating profit

---39.67M

---37.12M

Net non-operating interest income (expenses)

Non-operating interest income

--1.71M

--1.77M

Non-operating interest expense

--10.00K

--4.00K

Special income (expenses)

---109.00K

---383.00K

Other non-operating income (expenses)

---117.00K

---150.00K

Income before tax

---38.20M

---35.88M

Income tax

---63.00K

--47.00K

Income after tax

---38.14M

---35.93M

Net income from continuous operations

---38.26M

---35.93M

Other net gains and losses

---126.00K

----

Net income attributable to controlling interests

---38.26M

---35.93M

Net income attributable to common shareholders

---38.26M

---35.93M

Basic earnings per share

---6.77

---0.76

Diluted earnings per share

---6.77

---0.76

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

